Jubilant Life Sciences planning to raise Rs 750 crore via NCDs

25 Jun 2018 Evaluate

Jubilant Life Sciences is planning to raise funds up to an amount of Rs 750 crore by issuance of Non-Convertible Debentures (NCDs). The meeting of the Board of Directors of the company is scheduled to be held on June 27, 2018, to consider the same.

Jubilant Life Sciences is an integrated global pharmaceutical and life sciences company engaged in Pharmaceuticals, Life Science Ingredients and Drug Discovery Solutions.


Jubilant Pharmova Share Price

993.60 -53.05 (-5.07%)
19-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1673.55
Dr. Reddys Lab 1166.45
Cipla 1391.20
Zydus Lifesciences 881.10
Lupin 2178.20
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×